Algin and Gallbladder attack - a phase IV clinical study of FDA data

Summary:

Gallbladder attack is reported only by a few people who take Algin.

The phase IV clinical study analyzes which people take Algin and have Gallbladder attack. It is created by eHealthMe based on reports of 1,255 people who have side effects while taking Algin from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 29, 2023

1,255 people reported to have side effects when taking Algin.
Among them, 1 person (0.08%) has Gallbladder attack.

What is Algin?

Algin has active ingredients of algin. eHealthMe is studying from 1,257 Algin users for its effectiveness, alternative drugs and more.

What is Gallbladder attack?

Gallbladder attack (gallstones, gallbladder disease and gallbladder pain) is found to be associated with 1,300 drugs and 874 conditions by eHealthMe.

Number of Algin and Gallbladder attack reports submitted per year:

Gender of people who have Gallbladder attack when taking Algin *:

female: 0.0 %
male: 100 %

Age of people who have Gallbladder attack when taking Algin *:

Common drugs people take besides Algin *:

Common side effects people have besides Gallbladder attack *:

Renal Tubular Disorder (disease of kidney tubules): 1 person, 100.00%
Renal Disorder (kidney disease): 1 person, 100.00%
Kidney Stones: 1 person, 100.00%
Jaundice - Yellow Skin (a yellowish pigmentation of the skin): 1 person, 100.00%
Hyperbilirubinaemia (excess of bilirubin in the blood): 1 person, 100.00%
Haemoglobin Decreased: 1 person, 100.00%
Gallstones (stone formation by bile component): 1 person, 100.00%
Anaemia (lack of blood): 1 person, 100.00%

Common conditions people have *:

Nausea (feeling of having an urge to vomit): 1 person, 100.00%
Indigestion: 1 person, 100.00%
Hiv Infection: 1 person, 100.00%
Hepatitis C: 1 person, 100.00%
Drug Dependence: 1 person, 100.00%
Anaemia (lack of blood): 1 person, 100.00%
Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Algin and have Gallbladder attack?

Check whether Gallbladder attack is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Gallbladder attack and when was it recovered:

Gallbladder attack in Algin

Expand to all the drugs that have ingredients of algin:

Gallbladder attack and drugs with ingredients of algin

Alternative drugs to, pros and cons of Algin:

Algin (1,257 reports)

Gallbladder attack treatments and more:

Gallbladder attack (3,575 reports)

COVID vaccines that are related to Gallbladder attack:

Common drugs associated with Gallbladder attack:

Yasmin: 713 reports
Yaz: 663 reports
Profen: 231 reports
Ibuprofen: 231 reports
Ibu: 231 reports
Drospirenone and ethinyl estradiol: 186 reports
Sandostatin: 178 reports
Sandostatin lar: 157 reports
Humira: 136 reports
Omeprazole: 129 reports

All the drugs that are associated with Gallbladder attack:

Gallbladder attack (1,300 drugs)

Common conditions associated with Gallbladder attack:

All the conditions that are associated with Gallbladder attack:

Gallbladder attack (874 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on algin (the active ingredients of Algin) and Algin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.